PATENT CLAIM ANALYSIS

Application Number: 16011378
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "001000"]

Abstract:
The present invention relates to compositions comprising therapeutic and/or diagnostic anionic agents together with cationic peptides and their use in methods for delivering the anionic agents to bladder cells.

Claim (Index 2):
The method of  claim 1  which is a method of treating a subject with overactive bladder, comprising administering into the bladder of the subject a therapeutic amount of an antisense oligonucleotide toward nerve growth factor in combination with a cationic peptide(s) in an amount that promotes the uptake of the antisense oligonucleotide into bladder cells to reduce the level of nerve growth factor and reduce the frequency of urination and/or feeling of urgency to urinate.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 94.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14846536', '10835151', '15056386', '10018103', '15698486']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6804583893195656
- 35 USC 102 Novelty (BERT): 0.5705722335059431
- Combined Prediction Score: 0.6694697737382033
- Mean Citation Score: 296.71399800000006
- Max Citation Score: 537.62634
- Similarity Product: 332.0012206146956

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test